Search results
Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Morningstar· 2 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Ties with Jersey will stay strong - French ambassador to UK
BBC News· 4 days agoThe French ambassador to the UK said her country’s ties with Jersey would stay strong despite...
PepGen (NASDAQ:PEPG) Reaches New 1-Year High at $18.38
ETF DAILY NEWS· 22 hours agoShares of PepGen Inc. (NASDAQ:PEPG – Get Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as $18.38 and last traded at $18.11, with a volume of ...
Sarepta Therapeutics (NASDAQ:SRPT) Trading 4.1% Higher
ETF DAILY NEWS· 6 days agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report)’s share price traded up 4.1% during trading on Friday . Several analysts recently weighed in on SRPT shares. Piper Sandler started ...
Clare Kahn, director at Solid Biosciences, buys $8.4k in stock By Investing.com
Investing.com· 3 days agoClare Kahn, a director of Solid Biosciences Inc. (NASDAQ:SLDB), a company specializing in biological...
Prime Video's Upcoming NHL Docuseries Gives 'Unprecedented Access' to Top Players
Movieguide· 4 days agoPrime Video has just acquired the rights to a new NHL docuseries that will include “unprecedented...
Solid Biosciences Inc. (NASDAQ:SLDB) Receives $16.00 Consensus Price Target from Brokerages
ETF DAILY NEWS· 1 day agoSeveral research analysts have recently weighed in on SLDB shares. Piper Sandler began coverage on Solid Biosciences in a report on Friday, May 31st. William Blair reiterated an “outperform” ...
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
Lodi News-Sentinel· 1 day agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Dyne Therapeutics COO sells over $1.3m in company stock By Investing.com
Investing.com· 1 day agoIn a recent move that has caught the attention of investors, Susanna Gatti High, the Chief Operating...
GMs, agents predict the NHL offseason: Stamkos' decision, goalie carousel, Utah's big swing(s)
ESPN· 3 days agoGreg Wyshynski is ESPN's senior NHL writer. When the final pick of the 2024 NHL draft is selected,...
